Relationship between the oxidative stress biomarkers and coronary heart disease: Pathogenesis to therapeutic aspects

Aneeza Waris Hussain Rathore1, Hira Naveed1, Atif Nadeem1

  • 1Department of Cardiology, Army Cardiac Hospital/CMH Lahore Medical College, Lahore 54000, Punjab, Pakistan.

World Journal of Cardiology
|February 16, 2026
PubMed

Insights

Oxidative stress and inflammation are key drivers in coronary heart disease (CHD) development and progression. This review highlights crucial oxidative stress biomarkers and strategies to manage them in CHD patients.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Pathophysiology

Background:

  • Coronary heart disease (CHD) pathophysiology involves oxidative stress and inflammation, contributing to atherosclerosis.
  • Reduced antioxidant defenses and elevated oxidative stress accelerate coronary artery disease (CAD) development and progression.
  • Numerous oxidative stress biomarkers are associated with CAD.

Purpose of the Study:

  • To summarize the role of various oxidative stress biomarkers in the pathogenesis of CHD.
  • To discuss the implications of oxidative stress in coronary artery disease.
  • To explore therapeutic strategies for managing oxidative stress in CHD.

Main Methods:

  • Literature review focusing on oxidative stress biomarkers in CHD.
  • Analysis of the role of specific biomarkers including paraoxonase, nitrotyrosine, glutathione peroxidase, advanced glycation end-products, 8-hydroxydeoxyguanosine, myeloperoxidase, superoxide dismutase, malondialdehyde, isoprostanes, catalase, and reactive oxidative metabolites.
  • Synthesis of information on the link between oxidative stress and CHD pathogenesis.

Main Results:

  • Paraoxonase, nitrotyrosine, glutathione peroxidase, advanced glycation end-products, 8-hydroxydeoxyguanosine, myeloperoxidase, superoxide dismutase, malondialdehyde, isoprostanes, catalase, and reactive oxidative metabolites are significant in CHD pathogenesis.
  • Oxidative stress biomarkers provide insights into the mechanisms of CHD.
  • These biomarkers are implicated in the development and progression of atherosclerosis.

Conclusions:

  • Managing oxidative stress indicators is crucial for controlling CHD.
  • Lifestyle modifications and pharmacological interventions targeting reactive oxygen species are key strategies.
  • Understanding oxidative stress biomarkers aids in CHD management and treatment.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
559
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
737
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
590
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
619
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
459